Results 131 to 140 of about 6,064 (187)

A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy. [PDF]

Front Immunol
Kuska J, Kostyra J, Pinot L, Egorov E, Jelveh N, Martinez Carrera LA, Zhang C, Khorkova S, Assenmacher M, Orentas R, Mueller S, Hidalgo JV.   +11 more
europepmc   +1 more source

Characterisation of tumor-infiltrating gamma-delta T cells in human colorectal cancer with MHC-I loss. [PDF]

Clin Transl Immunology
Li TA, Quigley LT, Chan KF, Williams DS, Mielke LA, Behren A, Da Gama Duarte J.   +6 more
europepmc   +1 more source

Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapies. [PDF]

Nat Commun
Fisher J, Wu Y, Abate-Daga D, Barisa M, Lamb L.   +4 more
europepmc   +1 more source

Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging. [PDF]

PLoS One
Torrent C, Gagliardi C, Fülle N, Antignano I, Bernis ME, Stork M, Bano D, Capasso M, Keane L.   +8 more
europepmc   +1 more source

Production and Evaluation of Chimeric Antigen Receptor (CAR)-γδ T Cells

Background: Chimeric antigen receptor (CAR)-T cell therapy has been successful in clinics, but complications and side-effects hamper wide application. Gamma delta (γδ) T cells can recognize antigens without MHC restriction, reduceing the risk of graft ...
김민송
core  

<i>Ex vivo</i> cytokine responses and metabolic reprogramming are associated with γδ T cell differentiation in <i>Plasmodium falciparum</i> placental malaria. [PDF]

Front Immunol
Nana Mbianda CM, Kwanou Tchakounte BD, Bitye Zambo BM, Ntankheuh Tchinkou J, Atchombat Nyasse D, Fogang B, Argüello RJ, Ayong L, Megnekou R.   +8 more
europepmc   +1 more source

Translational potential of γδ T cells in hematologic diseases: from immunobiology to therapeutic innovation. [PDF]

Front Immunol
Zhou X, Zhai M, Zhang Z, Zhang G.
europepmc   +1 more source

Anti-tumoral immune response and bisphosphonates [PDF]

Hirvasniemi, Petra J
core  

CXCR3 signaling promotes Delta One T cell recruitment and antitumor efficacy in colorectal cancer. [PDF]

J Immunother Cancer
Carreira M, Barros L, Cruz RM, Ferreira C, Costa C, Ferreira CM, Mensurado S, Silva-Santos B, Blanco-Domínguez R.   +8 more
europepmc   +1 more source